X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Lupin Ltd Fact Sheet, Lupin Ltd Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Fact Sheet   (LUPL)

Here is the latest financial fact sheet of Lupin Ltd. For more details, see the Lupin Ltd quarterly results and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

LUPIN LTD Price History

Price Rs 824.4
Mkt Cap Rs m 371,919
Vol '000 126.9
P/E X 20.3
P/CF X 10.7
EPS (TTM) Rs 40.5
% ch % 0.3
No. of shares m 451.14
% ch week % 0.4
% ch 1-mth % -9.0
% ch 12-mth % -42.8
52 week H/L Rs 1,498.4/782.1
(As on Feb 16, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LUPIN LTD Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
LUPIN LTD EQUITY SHARE DATA
High Rs6391,0032,0372,1271,750 
Low Rs5076069041,2941,384 
Sales per share (Unadj.) Rs215.4251.7280.3316.4387.4 
Earnings per share (Unadj.) Rs29.441.053.550.256.6 
Diluted earnings per shareRs29.140.753.350.156.7 
Cash flow per share (Unadj.) Rs36.846.863.161.076.8 
Dividends per share (Unadj.) Rs4.006.007.507.507.50 
Adj. dividends per shareRs3.975.967.477.497.51 
Dividend yield (eoy) %0.70.70.50.40.5 
Book value per share (Unadj.) Rs116.3154.6204.1247.8298.9 
Adj. book value per shareRs115.4153.6203.3247.4299.2 
Shares outstanding (eoy) m447.53448.38449.49450.58451.58 
Bonus/Rights/Conversions  -ESOPESOP-ESOPS 
Price / Sales ratio x2.73.25.25.44.0 
Avg P/E ratio x19.519.627.534.127.7 
P/CF ratio (eoy) x15.617.223.328.020.4 
Price / Book Value ratio x4.95.27.26.95.2 
Dividend payout %13.614.614.014.913.2 
Avg Mkt Cap Rs m256,435360,767660,975770,740707,513 
No. of employees `000NANA14.216.416.8 
Total wages/salary Rs m12,66614,64717,47321,41628,495 
Avg. sales/employee Rs ThNMNM8,874.38,718.510,418.3 
Avg. wages/employee Rs ThNMNM1,230.71,309.81,697.0 
Avg. net profit/employee Rs ThNMNM1,692.71,382.61,523.0 
LUPIN LTD INCOME DATA
Net Sales Rs m96,413112,866125,997142,555174,943 
Other income Rs m2791,1652,3981,8521,065 
Total revenues Rs m96,692114,031128,395144,407176,008 
Gross profit Rs m22,70030,02836,19636,85444,931 
Depreciation Rs m3,3222,6104,3474,8719,122 
Interest Rs m410267985951,525 
Profit before tax Rs m19,24628,31734,14833,23935,349 
Minority Interest Rs m-263-331-412-88-72 
Prior Period Items Rs m0004983 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m5,8429,6229,70410,5939,785 
Profit after tax Rs m13,14218,36424,03222,60725,575 
Gross profit margin %23.526.628.725.925.7 
Effective tax rate %30.434.028.431.927.7 
Net profit margin %13.616.319.115.914.6 
LUPIN LTD BALANCE SHEET DATA
Current assets Rs m51,43161,00578,04098,874119,542 
Current liabilities Rs m30,06926,29634,63350,61261,206 
Net working cap to sales %22.230.834.533.933.3 
Current ratio x1.72.32.32.02.0 
Inventory Days Days7469738476 
Debtors Days Days83807711690 
Net fixed assets Rs m28,03630,01949,213114,194131,660 
Share capital Rs m895897899901903 
"Free" reserves Rs m49,55467,92290,833110,733134,073 
Net worth Rs m52,04269,31691,732111,634134,976 
Long term debt Rs m2,4711,5101,01853,73956,478 
Total assets Rs m89,139102,060132,610226,249266,073 
Interest coverage x47.9107.3349.156.924.2 
Debt to equity ratio x0000.50.4 
Sales to assets ratio x1.11.11.00.60.7 
Return on assets %15.218.318.210.310.2 
Return on equity %25.326.526.220.318.9 
Return on capital %35.639.936.520.419.3 
Exports to sales %44.850.746.447.20 
Imports to sales %8.78.68.87.20 
Exports (fob) Rs m43,15757,17758,48267,2440 
Imports (cif) Rs m8,3919,65411,05710,1990 
Fx inflow Rs m44,74963,07662,59371,40581,885 
Fx outflow Rs m13,82016,48016,59217,80721,506 
Net fx Rs m30,92946,59646,00153,59860,378 
LUPIN LTD CASH FLOW
From Operations Rs m 12,510 20,039 27,331 -3,824 41,148 
From Investments Rs m -5,219 -8,585 -10,545 -69,617 -25,287 
From Financial Activity Rs m -6,628 -8,571 -1,969 58,364 4,332 
Net Cashflow Rs m 663 2,883 14,817 -15,077 20,193 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 46.6%
Foreign collaborators 0.2%
Indian inst/Mut Fund 11.3%
FIIs 31.9%
ADR/GDR 0.0%
Free float 10.1%
Shareholders 98,259
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 159, C.S.T. Road, Kalina, Santacruz (E), Mumbai - 400 098
E-MAIL rajvardhansatam@lupinpharma.com WEB www.lupinworld.com
TELEPHONE (022) 6640 2323 FAX (022) 2652 8806
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT In-house
AUDITOR Deloitte Haskins & Sells
CHM: D. B. Gupta COMP SEC: R. V. Satam YEAR OF INC: 1983 BSE CODE: 500257 FV (Rs): 2 DIV YIELD (%): 0.9

More Pharmaceuticals Company Fact Sheets:   ASTRAZENECA PHARMA  ALEMBIC LTD  SUN PHARMA  DISHMAN PHARMA  AJANTA PHARMA  

Compare LUPIN LTD With:   ASTRAZENECA PHARMA  ALEMBIC LTD  SUN PHARMA  DISHMAN PHARMA  AJANTA PHARMA  

Compare LUPIN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Views on news

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON LUPIN LTD

LUPIN LTD - NOVARTIS COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS